Flanagan W. Michael sold RNA
September 11, 2025 · Form 4 insider transaction
Flanagan W. Michael sold 20,000 shares of Atrium Therapeutics, Inc. at $38.94 per share, a transaction worth $778.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The exercise and sales reported in this report were effected pursuant to a Rule 10b5-1 trading plan previously adopted on June 12, 2024 by the Reporting Person.; This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.85 to $41.52. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.